Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226330
Status:
TERMINATED
Last Update Posted:
2010-11-19
First Post:
2005-09-23
Brief Title:
GALLEX 6 Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-23
First Submit QC Date:
September 23 2005
Study First Post Date:
2005-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-11-18
Last Update Post Date:
2010-11-19
Last Update Post Date Type:
ESTIMATED